Stock analysts at StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research note issued on Monday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of NYSE:CO opened at $2.99 on Monday. The firm has a fifty day moving average price of $1.60 and a 200 day moving average price of $1.38. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The firm has a market cap of $363.44 million, a price-to-earnings ratio of 4.67 and a beta of 0.16.
Global Cord Blood Company Profile
Further Reading
- Five stocks we like better than Global Cord Blood
- What is the S&P/TSX Index?
- Is Spotify Stock Poised to Soar? Options Traders Think So
- Stock Market Sectors: What Are They and How Many Are There?
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- What Are Dividend Champions? How to Invest in the Champions
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.